PubRank

H Glossmann

Author PubWeight™ 154.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Glycoproteins of cell surfaces. A comparative study of three different cell surfaces of the rat. J Biol Chem 1971 5.25
2 Molecular weight determination of membrane protein and glycoprotein subunits by discontinuous gel electrophoresis in dodecyl sulfate. Methods Enzymol 1974 3.50
3 Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A 1996 3.39
4 alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. J Biol Chem 2001 2.77
5 Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A 1998 2.22
6 Plasma membrane protein subunit composition. A comparative study by discontinuous electrophoresis in sodium dodecyl sulfate. J Biol Chem 1971 1.74
7 Distribution of high-conductance Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve terminals. J Neurosci 1996 1.71
8 Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci 1998 1.69
9 Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet 2000 1.61
10 Assay for calcium channels. Methods Enzymol 1985 1.60
11 Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy. J Mol Biol 2003 1.56
12 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J Clin Invest 2001 1.55
13 Molecular cloning and expression of the human delta7-sterol reductase. Proc Natl Acad Sci U S A 1998 1.49
14 Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndrome. Nat Genet 1999 1.47
15 Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron 1996 1.46
16 Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. J Biol Chem 1998 1.44
17 Use of unlicensed nitric oxide in Austria. Lancet 1997 1.38
18 Evidence of multiple receptor sites within the putative calcium channel. Naunyn Schmiedebergs Arch Pharmacol 1982 1.37
19 Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine. Proc Natl Acad Sci U S A 1991 1.31
20 Endogenous calcium channels in human embryonic kidney (HEK293) cells. Br J Pharmacol 1996 1.31
21 (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors. Eur J Pharmacol 1989 1.28
22 Purified skeletal muscle 1,4-dihydropyridine receptor forms phosphorylation-dependent oligomeric calcium channels in planar bilayers. Proc Natl Acad Sci U S A 1988 1.28
23 Properties of angiotensin II receptors in the bovine and rat adrenal cortex. J Biol Chem 1974 1.25
24 Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations. J Biol Chem 1987 1.25
25 Binding of 3 H-desmethylphalloin to isolated plasma membranes from rat liver. Naunyn Schmiedebergs Arch Pharmacol 1972 1.21
26 High affinity of sigma 1-binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase. Br J Pharmacol 1997 1.20
27 Differential effects of Ca2+ channel beta1a and beta2a subunits on complex formation with alpha1S and on current expression in tsA201 cells. J Biol Chem 1998 1.19
28 Calcium channels from Cyprinus carpio skeletal muscle. Proc Natl Acad Sci U S A 1991 1.17
29 Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine. Naunyn Schmiedebergs Arch Pharmacol 1983 1.17
30 Angiotensin II receptors in bovine adrenal cortex. Modification of angiotensin II binding by guanyl nucleotides. J Biol Chem 1974 1.14
31 Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels. Proc Natl Acad Sci U S A 1990 1.13
32 Purification of the putative calcium channel from skeletal muscle with the aid of [3H]-nimodipine binding. Naunyn Schmiedebergs Arch Pharmacol 1983 1.13
33 Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel. FEBS Lett 1987 1.13
34 Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. J Biol Chem 2000 1.12
35 Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel. Eur J Biochem 1986 1.12
36 Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. J Biol Chem 1995 1.12
37 (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle. FEBS Lett 1984 1.11
38 Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits. Biochemistry 1996 1.11
39 Transfer of high sensitivity for benzothiazepines from L-type to class A (BI) calcium channels. J Biol Chem 1996 1.10
40 Association of calcium channel alpha1S and beta1a subunits is required for the targeting of beta1a but not of alpha1S into skeletal muscle triads. Proc Natl Acad Sci U S A 1998 1.09
41 Analysis of membrane protein self-association in lipid systems by fluorescence particle counting: application to the dihydropyridine receptor. Biochemistry 1997 1.08
42 The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends Pharmacol Sci 1997 1.07
43 Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. Biochem J 2000 1.06
44 Renal receptors for calcitonin. Binding and degradation of hormone. J Biol Chem 1973 1.06
45 Photoaffinity labelling of Ca2+ channels with [3H]azidopine. FEBS Lett 1984 1.03
46 Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188. J Biol Chem 1997 1.02
47 Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies. Mol Pharmacol 1993 1.02
48 Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110. Naunyn Schmiedebergs Arch Pharmacol 1983 0.99
49 Genetic defects in postsqualene cholesterol biosynthesis. Trends Endocrinol Metab 2000 0.98
50 Solid phase radioimmunoassay for cyclic AMP using staphylococcal protein A-antibody adsorbent. Naunyn Schmiedebergs Arch Pharmacol 1977 0.98
51 Calcium channels and calcium channel drugs: recent biochemical and biophysical findings. Arzneimittelforschung 1985 0.96
52 Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action. J Biol Chem 1990 0.96
53 Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics. Biochemistry 1996 0.96
54 Insect calcium channels. Molecular cloning of an alpha 1-subunit from housefly (Musca domestica) muscle. FEBS Lett 1994 0.96
55 Neurotoxic aminoglycoside antibiotics are potent inhibitors of [125I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes. Naunyn Schmiedebergs Arch Pharmacol 1987 0.95
56 Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140. J Biol Chem 1991 0.95
57 [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength. Arzneimittelforschung 1982 0.95
58 Histidine77, glutamic acid81, glutamic acid123, threonine126, asparagine194, and tryptophan197 of the human emopamil binding protein are required for in vivo sterol delta 8-delta 7 isomerization. Biochemistry 1999 0.95
59 Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity. J Biol Chem 1996 0.95
60 Calcium channels. Vitam Horm 1988 0.95
61 Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists. FEBS Lett 1983 0.95
62 Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit. Biochemistry 1995 0.94
63 Calcium channels: the beta-subunit increases the affinity of dihydropyridine and Ca2+ binding sites of the alpha 1-subunit. FEBS Lett 1994 0.94
64 Phlorizin receptors in isolated kidney brush border membranes. J Biol Chem 1972 0.94
65 Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation. FEBS Lett 1983 0.94
66 Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine. J Cardiovasc Pharmacol 1984 0.94
67 Quercetin inhibits tyrosine phosphorylation by the cyclic nucleotide-independent, transforming protein kinase, pp60src. Naunyn Schmiedebergs Arch Pharmacol 1981 0.94
68 (-)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites. Naunyn Schmiedebergs Arch Pharmacol 1984 0.93
69 Purified calcium channels have three allosterically coupled drug receptors. FEBS Lett 1986 0.93
70 Expression of the purported sigma(1) (sigma(1)) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. J Chem Neuroanat 2000 0.93
71 Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with (+)-cis-azidodiltiazem and anti-ligand antibodies. J Biol Chem 1990 0.92
72 Identification of putative calcium channels in skeletal muscle microsomes. FEBS Lett 1982 0.92
73 Calcium- and potassium-channel blockers interact with alpha-adrenoceptors. Mol Cell Endocrinol 1980 0.92
74 Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart. Br J Pharmacol 1985 0.92
75 Alpha noradrenergic receptors in brain membranes: sodium, magnesium and guanyl nucleotides modulate agonist binding. Naunyn Schmiedebergs Arch Pharmacol 1979 0.92
76 Target size analysis and molecular properties of Ca2+ channels labelled with [3H]verapamil. Eur J Biochem 1984 0.91
77 Pharmacological analysis of sterol delta8-delta7 isomerase proteins with [3H]ifenprodil. Mol Pharmacol 1998 0.91
78 Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action. Mol Pharmacol 1993 0.91
79 Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter. Eur J Biochem 1985 0.90
80 Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors. Biochemistry 1996 0.90
81 Novel 1,4-dihydropyridine (Bay K 8644) facilitates calcium-dependent [3H]noradrenaline release from PC 12 cells. J Neurochem 1984 0.90
82 Sequence differences between alpha1C and alpha1S Ca2+ channel subunits reveal structural determinants of a guarded and modulated benzothiazepine receptor. J Biol Chem 1999 0.90
83 Subunit composition of skeletal muscle transverse tubule calcium channels evaluated with the 1,4-dihydropyridine photoaffinity probe, [3H]azidopine. EMBO J 1985 0.90
84 WIN 17317-3, a new high-affinity probe for voltage-gated sodium channels. Biochemistry 1999 0.90
85 Association of the src-gene product of Rous sarcoma virus with a pyruvate-kinase inactivation factor. Mol Cell Endocrinol 1981 0.90
86 [125I] N6-p-Hydroxyphenylisopropyladenosine, a new ligand for Ri adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 1982 0.90
87 Alpha adrenoceptors in rat brain: direct identification with prazosin. Naunyn Schmiedebergs Arch Pharmacol 1979 0.89
88 A unique fluorescent phenylalkylamine probe for L-type Ca2+ channels. Coupling of phenylalkylamine receptors to Ca2+ and dihydropyridine binding sites. J Biol Chem 1992 0.88
89 Purification and amino-terminal sequencing of the high affinity phenylalkylamine Ca2+ antagonist binding protein from guinea pig liver endoplasmic reticulum. J Biol Chem 1994 0.88
90 Identification of voltage operated calcium channels by binding studies: differentiation of subclasses of calcium antagonist drugs with 3H-nimodipine radioligand binding. J Recept Res 1983 0.87
91 Calcium channels: basic properties as revealed by radioligand binding studies. J Cardiovasc Pharmacol 1985 0.87
92 Chimeric L-type Ca2+ channels expressed in Xenopus laevis oocytes reveal role of repeats III and IV in activation gating. J Physiol 1995 0.86
93 Similarities between a phosphoprotein (pp60src)-associated protein kinase of Rous sarcoma virus and a cyclic adenosine 3':5'-monophosphate-independent protein kinase that phosphorylates pyruvate kinase type M2. Cancer Res 1980 0.86
94 Molecular structure of rat brain apamin receptor: differential photoaffinity labeling of putative K+ channel subunits and target size analysis. Biochemistry 1986 0.86
95 Molecular weights of pig liver cell membrane proteins. Hoppe Seylers Z Physiol Chem 1970 0.86
96 The dihydropyridine niguldipine inhibits T-type Ca2+ currents in atrial myocytes. Pflugers Arch 1992 0.85
97 Molecular basis of drug interaction with L-type Ca2+ channels. J Bioenerg Biomembr 1998 0.85
98 125I-iodipine, a new high affinity ligand for the putative calcium channel. Naunyn Schmiedebergs Arch Pharmacol 1984 0.85
99 Solubilization of a mammalian beta-adrenergic receptor. Naunyn Schmiedebergs Arch Pharmacol 1978 0.84
100 Putative calcium channel molecular weight determination by target size analysis. Naunyn Schmiedebergs Arch Pharmacol 1983 0.84
101 Mechanism of dihydropyridine interaction with critical binding residues of L-type Ca2+ channel alpha 1 subunits. J Biol Chem 2001 0.84
102 Cloning and functional expression of a neuronal calcium channel beta subunit from house fly (Musca domestica). J Biol Chem 1994 0.84
103 Improved micro-perfusion chamber for multiple and rapid solution exchange in adherent single cells. Pflugers Arch 1995 0.84
104 Molecular genetics of the Smith-Lemli-Opitz syndrome and postsqualene sterol metabolism. Curr Opin Lipidol 1999 0.84
105 Activation of chromaffin cell Ca2+ channels by novel dihydropyridine. Nature 1985 0.83
106 Beta-adrenergic receptors in guinea-pig myocardial tissue. Naunyn Schmiedebergs Arch Pharmacol 1976 0.83
107 Radioligand assay for angiotensin II receptors. Methods Enzymol 1985 0.83
108 Cation dependence of high-affinity angiotensin II binding to adrenal cortex receptors. Science 1974 0.83
109 Pharmacology and structure of high conductance calcium-activated potassium channels. Cell Signal 1994 0.83
110 Reversible labeling of a chemosensitizer binding domain of p-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor. Biochemistry 1996 0.83
111 Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels. Br J Pharmacol 1993 0.83
112 A rapid procedure for the purification of cardiac 1,4-dihydropyridine receptors from porcine heart. Eur J Pharmacol 1991 0.83
113 Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance. Biochem Pharmacol 1995 0.82
114 Complex molecular mechanism for dihydropyridine binding to L-type Ca(2+)-channels as revealed by fluorescence resonance energy transfer. Biochemistry 1994 0.82
115 Cyanogen bromide cleavage of Proteus mirabilis flagellin. Maleylation of cyanogen bromide peptides. Hoppe Seylers Z Physiol Chem 1972 0.82
116 Ca2+ antagonist receptor sites on human red blood cell membranes. Eur J Pharmacol 1985 0.82
117 Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implications for pharmacokinetics and access to dihydropyridine binding site. J Mol Cell Cardiol 1995 0.81
118 [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain. Naunyn Schmiedebergs Arch Pharmacol 1989 0.81
119 Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart. Naunyn Schmiedebergs Arch Pharmacol 1986 0.80
120 Stereospecific regulation of [3H]inositol monophosphate accumulation by calcium channel drugs from all three main chemical classes. Eur J Pharmacol 1986 0.80
121 Calcium channels: evidence for oligomeric nature by target size analysis. EMBO J 1983 0.80
122 L-asparaginase A from Escherichia coli. The molecular weight of the subunit and the demonstration of an intramolecular disulfide bridge. Hoppe Seylers Z Physiol Chem 1971 0.79
123 The molecular pharmacology and structural features of calcium channels. Br J Clin Pharmacol 1985 0.79
124 L-type calcium channels: binding domains for dihydropyridines and benzothiazepines are located in close proximity to each other. Biochemistry 1997 0.79
125 [On the question of native hemoglobins in the larvae of Chironomus thummi thummi]. Hoppe Seylers Z Physiol Chem 1968 0.79
126 Adrenal cortex adenylate cyclase. Specific binding sites for 5'-guanylyl-imidodiphosphate in partially purified plasma membranes from bovine adrenal cortex. Naunyn Schmiedebergs Arch Pharmacol 1975 0.79
127 Radiation inactivation of alpha 1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 1983 0.79
128 Uneventful self poisoning with a very high dose of captopril. Toxicology 1990 0.79
129 Adrenal cortex adenylate cyclase. Comparison between the action of GTP and 5'-guanylyl-imidodiphosphate on the particulate enzyme from bovine adrenal cortex and rat adrenals. Naunyn Schmiedebergs Arch Pharmacol 1974 0.79
130 Naftopidil, a new alpha-adrenoceptor blocking agent with calcium antagonistic properties: characterization of Ca2+ antagonistic effects. J Cardiovasc Pharmacol 1991 0.79
131 [Data on sweet almond emulsin. Further characterization of components A and B]. Hoppe Seylers Z Physiol Chem 1970 0.79
132 A novel 1,4-dihydropyridine-binding site on mitochondrial membranes from guinea-pig heart, liver and kidney. Biochem J 1988 0.78
133 Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel. Biochem J 1988 0.78
134 The preparation of brush border membranes from rat kidney using an aqueous two-phase polymer system. Naunyn Schmiedebergs Arch Pharmacol 1974 0.78
135 Novel sites for phenylalkylamines: characterisation of a sodium-sensitive drug receptor with (-)-[3H]emopamil. Eur J Pharmacol 1991 0.78
136 Bovine adrenal cortex adenylate cyclase: properties of the particulate enzyme and effects of guanyl nucleotides. Naunyn Schmiedebergs Arch Pharmacol 1975 0.78
137 Adrenal cortex adenylate cyclase. In vitro acitivity of ACTH fragments and analogues. Naunyn Schmiedebergs Arch Pharmacol 1976 0.78
138 Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand. Biochem J 1987 0.78
139 alpha-Adrenoceptors in rat brain: sodium changes the affinity of agonists for prazosin sites. Eur J Pharmacol 1980 0.77
140 Cation sensitivity of [125I]heat binding to alpha 1-adrenoceptors in rat cerebral cortex membranes. Eur J Pharmacol 1981 0.77
141 [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties. Mol Pharmacol 1992 0.77
142 Alpha 2 adrenoceptors in rat brain: the divalent cation site. Naunyn Schmiedebergs Arch Pharmacol 1980 0.77
143 Characteristics of the binding of the antihypertensive agent moxonidine to alpha 2-adrenoceptors in rat brain membranes. Arzneimittelforschung 1988 0.76
144 Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channel. Mol Pharmacol 1990 0.76
145 Soluble bovine adrenal cortex guanylate cyclase: effect of sodium nitroprusside, nitrosamines, and hydrophobic ligands on activity, substrate specificity and cation requirement. Naunyn Schmiedebergs Arch Pharmacol 1978 0.76
146 Mammalian beta-adrenoceptors: concomitant biospecific elution with protein kinase activity from Sepharose-alprenolol. Eur J Pharmacol 1981 0.76
147 Polymerization behaviour of carboxypeptidase B treated Proteus mirabilis flagellin. Hoppe Seylers Z Physiol Chem 1970 0.75
148 Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166. Naunyn Schmiedebergs Arch Pharmacol 1988 0.75
149 [Sweet almond emulsin. Optical properties of both beta-glucosidases A and B]. Hoppe Seylers Z Physiol Chem 1970 0.75
150 Angiotensin II receptors of the adrenal gland: location and modulation by cations and guanyl nucleotides. Acta Physiol Lat Am 1974 0.75
151 Phlorizin receptors in kidney brush border membranes. Hoppe Seylers Z Physiol Chem 1972 0.75
152 Proceedings: Regulatory nucleotide binding sites for adrenal cortex adenylate cyclase. Naunyn Schmiedebergs Arch Pharmacol 1975 0.75
153 Characterization of the drug receptors of the purified skeletal muscle calcium channel. Prog Clin Biol Res 1988 0.75
154 Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67. Mol Pharmacol 1993 0.75
155 Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue. Biochemistry 1995 0.75
156 Automatic peptide mapping with a liquid chromatograph. Hoppe Seylers Z Physiol Chem 1970 0.75
157 Effects of ion channel toxins and specific neurotoxins on the cyclic nucleotide content of cerebellar slices, primary brain cultures and neural cell lines. Naunyn Schmiedebergs Arch Pharmacol 1979 0.75
158 Effect of alpha-adrenoceptor agonists on cell membrane potential in renal epitheloid Madin Darby canine kidney cells. Eur J Pharmacol 1991 0.75
159 Proceedings: Angiotensin receptors in the adrenal cortex. Naunyn Schmiedebergs Arch Pharmacol 1974 0.75
160 Molecular approach to the calcium channel. Adv Myocardiol 1985 0.75
161 The mitochondrial high-capacity low-affinity (+/-)-[3H]nitrendipine binding site is regulated by nucleotides. Eur J Pharmacol 1988 0.75
162 The increase in hormone-stimulated adenylate cyclase activity following Rous sarcoma virus transformation. J Cell Physiol 1982 0.75
163 [125I]-HEAT, a selective, high-affinity, high specific activity ligand for alpha 1-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 1981 0.75
164 Hydrophobic calcium channel ligands: methodical problems and their solution. Am J Cardiol 1989 0.75
165 Adrenal cortex adenylate cyclase. In vitro modification of the enzyme by cholera toxin. Naunyn Schmiedebergs Arch Pharmacol 1977 0.75
166 Phosphatidylinositol turnover as a functional probe for neuronal Ca2+ channels. Prog Clin Biol Res 1988 0.75
167 Investigations on the mechanism of cyclic guanosine monophosphate increase due to depolarizing agents as studied with sea anemone toxin II in mouse cerebellar slices. Naunyn Schmiedebergs Arch Pharmacol 1979 0.75
168 [Polarographic measurement of critical oxygen pressure in heart muscle sarcosomes]. Z Naturforsch B 1969 0.75
169 The identification of cytoplasmic membrane calcium-entry channels by ligand-binding studies. Biochem Soc Trans 1984 0.75
170 [Hemoglobins. 18. Isoelectric focussing of hemoglobins (erythrocruorins) from insects (Chironomus thummi, thummi, Diptera)]. Hoppe Seylers Z Physiol Chem 1970 0.75
171 Phlorizin receptors in isolated kidney brush border membranes. Differential enzymatic modification of high-affinity receptors and unspecific binding sites. Biochim Biophys Acta 1973 0.75
172 Adrenal cortex adenylate cyclase. Is Ca2+ involved in ACTH stimulation? Naunyn Schmiedebergs Arch Pharmacol 1976 0.75
173 Ionic modulation of alpha-adrenoceptors. J Cardiovasc Pharmacol 1982 0.75
174 [125I]-HEAT:fifty percent of the ligand can bind to the alpha1-adrenoceptors with extremely high affinity. Naunyn Schmiedebergs Arch Pharmacol 1982 0.75
175 [Disturbances by phalloidine of the permeability to cations of liver cell membranes]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol 1968 0.75